中文 | English
Return
Total: 114 , 1/12
Show Home Prev Next End page: GO
MeSH:(P-Glycoprotein*)

1.Recent updates on extranodal NK/T-cell lymphoma.

Won Seog KIM

Korean Journal of Medicine 2009;77(5):565-570

5.Does 3-O-Methyldopa(3-OMD) Inhibit the Binding of Levodopa to Plasma Protein.

Jin Woo BAE ; Sebastian HARDER

Korean Journal of Psychopharmacology 1999;10(2):180-184

7.Role of the ABCB1 Drug Transporter Polymorphisms in the Pharmacokinetics of Oseltamivir in Humans: a Preliminary Report.

Yu Jung CHA ; Jong Lyul GHIM

Journal of Korean Medical Science 2017;32(9):1542-1547

8.Clinical Significance of p53, P-glycoprotein, and Glutathione S transferase-pi in Advanced Non-Small Cell Lung Cancer.

Young Don JOO ; Chang Hak SOHN

Cancer Research and Treatment 2002;34(1):34-40

9.The Multidrug Resistance-related Protein and P-glycoprotein Expressions, and the Washout Rates of 99mTc-MIBI in Infiltrating Ductal Carcinoma of Breast, Correlation with the Response After Neoadjuvant Chemotherapy.

Hi Suk KWAK ; Young Tae BAE ; Koon Taek HAN ; In Joo KIM

Journal of Breast Cancer 2007;10(1):29-35

10.A Phase I Study of Oral Paclitaxel with a Novel P-Glycoprotein Inhibitor, HM30181A, in Patients with Advanced Solid Cancer.

Hyun Jung LEE ; Dae Seog HEO ; Joo Youn CHO ; Sae Won HAN ; Hye Jung CHANG ; Hyeon Gyu YI ; Tae Eun KIM ; Se Hoon LEE ; Do Youn OH ; Seock Ah IM ; In Jin JANG ; Yung Jue BANG

Cancer Research and Treatment 2014;46(3):234-242

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 114 , 1/12 Show Home Prev Next End page: GO